Veterinary Medicines

Nobivac L+DHPPi lyofilisaat en suspensie voor suspensie voor injectie voor honden

Authorised
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine parvovirus, strain 154, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
  • Leptospira interrogans, serovar Copenhageni, strain Ic-02-001, Inactivated
Download as PDF

Product identification

Medicine name:
Nobivac L+DHPPi lyofilisaat en suspensie voor suspensie voor injectie voor honden
Active substance:
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine parvovirus, strain 154, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
  • Leptospira interrogans, serovar Copenhageni, strain Ic-02-001, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Onderstepoort, Live
    4.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, strain Cornell, Live
    5.50
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain 154, Live
    7.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    4.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
    1300.00
    enzyme-linked immunosorbent assay unit/millilitre
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Copenhageni, strain Ic-02-001, Inactivated
    750.00
    enzyme-linked immunosorbent assay unit/millilitre
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Nederland B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 9483
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/02/2025
Download